Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Clinical evidence

VX22-147-010

12 evidence topics · 1 source

Objective
Location and study date
Study dates and status in the registry record
FieldRegistry entry
Recruitment status“Completed”
Study start (actual)“2023-07-19”
Primary completion (actual)“2023-09-02”
Study completion (actual)“2023-09-02”
First posted“2023-07-21”
Last update posted“2023-09-13”
Other study ID numbers“VX22-147-010”
Study design
Design details in the registry record
FieldRegistry entry
Study type“Interventional”
Phase“Phase 1”
Primary purpose“Treatment”
Allocation“Randomized”
Interventional model“Crossover Assignment”
Masking“None (Open Label)”
Eligibility criteria
Age range and healthy volunteers
FieldRegistry entry
Ages eligible“18 Years to 55 Years”
Sexes eligible“All”
Accepts healthy volunteers“Yes”
Treatment
Study outcomes
Rationale for using relative bioavailability and food effect on cmax and AUC0-inf as the primary endpoints
Statistical analysis description
Number of participants (Planned and analyzed)
Enrollment in the registry record
FieldRegistry entry
Enrollment (actual)“21”
Description of analysis sets

No evidence found.

Results
Participant disposition

No evidence found.

Baseline characteristics

No evidence found.

Efficacy results

No evidence found.

Health-related quality of life and patient-reported outcomes

Not applicable.

Safety results

No evidence found.

Study limitations
Summary: study limitations

VX22-147-010 enrolled 21 healthy adults aged 18 to 55 years at one United States site and compared a test tablet with a reference tablet, and the test tablet fed with fasted, in a three-period crossover with 5-day washouts. The study was completed on 2023-09-02, but the ClinicalTrials.gov record lists no posted results, and no publication or congress abstract reporting its results was identified. The registry record does not state the dose or the composition of the test meal.